TerminatedNCT03110575
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
Medication studyAges 18–75United States
Understand this study
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
- Listed locations
- Phoenix and 31 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 20, 2017
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 190
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT03110575
- Official title
Show the full official title
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Phoenix · Rogers · Beverly Hills
28 more locations
- Glendale
- Oakland
- Oceanside
- Orange
- Riverside
- San Diego
- Temecula
- Colorado Springs
- Jacksonville
- Lake City
- Lauderhill
- Tampa
- Atlanta
- New Bedford
- Flowood
- Las Vegas
- Berlin
- Cedarhurst
- New York
- Canton
- Cincinnati
- Dayton
- Oklahoma City
- Charleston
- Austin
- Dallas
- Houston
- San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tonix Pharmaceuticals, Inc.
Does this study involve medication?
Yes. The study involves medication, including TNX-102 SL.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
